BIOMAT Database Logo BIOMAT Database Logo

Extensive serum biomarker analysis in patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome. 2014

Masaki Shimizu, and Mondo Kuroda, and Natsumi Inoue, and Michio Konishi, and Noboru Igarashi, and Hiromichi Taneichi, and Hirokazu Kanegane, and Mika Ito, and Shigeru Saito, and Akihiro Yachie
Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Japan. Electronic address: shimizum@staff.kanazawa-u.ac.jp.

Proinflammatory cytokines are related to the pathogenesis of enterohemorrhagic Escherichia coli infection and hemolytic-uremic syndrome (HUS). We employed an antibody array that simultaneously detects 174 serum cytokines. We identified five serum biomarkers, namely insulin growth factor-binding protein-2, angiopoietin-2, soluble interleukin-6 receptor, soluble tumor necrosis factor receptor type II, and matrix metalloprotease protein-3 whose levels increased with the development of HUS. Furthermore, the levels of these cytokines were significantly increased in severe HUS compared with mild HUS. These cytokines might play an important role in the pathogenesis of HUS and may also be used to predict the severity of HUS.

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006463 Hemolytic-Uremic Syndrome A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE. Gasser's Syndrome,Gasser Syndrome,Gassers Syndrome,Hemolytic Uremic Syndrome,Syndrome, Hemolytic-Uremic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine

Related Publications

Masaki Shimizu, and Mondo Kuroda, and Natsumi Inoue, and Michio Konishi, and Noboru Igarashi, and Hiromichi Taneichi, and Hirokazu Kanegane, and Mika Ito, and Shigeru Saito, and Akihiro Yachie
[Successful treatment of enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome and acute encephalopathy].
July 2015, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
Masaki Shimizu, and Mondo Kuroda, and Natsumi Inoue, and Michio Konishi, and Noboru Igarashi, and Hiromichi Taneichi, and Hirokazu Kanegane, and Mika Ito, and Shigeru Saito, and Akihiro Yachie
Successful treatment of enterohemorrhagic Escherichia coli O111-induced acute encephalopathy and hemolytic-uremic syndrome with plasma diafiltration.
October 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
Masaki Shimizu, and Mondo Kuroda, and Natsumi Inoue, and Michio Konishi, and Noboru Igarashi, and Hiromichi Taneichi, and Hirokazu Kanegane, and Mika Ito, and Shigeru Saito, and Akihiro Yachie
Encephalopathy, disseminated intravascular coagulation, and hemolytic-uremic syndrome after infection with enterohemorrhagic Escherichia coli O111.
August 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Masaki Shimizu, and Mondo Kuroda, and Natsumi Inoue, and Michio Konishi, and Noboru Igarashi, and Hiromichi Taneichi, and Hirokazu Kanegane, and Mika Ito, and Shigeru Saito, and Akihiro Yachie
Hemolytic-uremic syndrome and enterohemorrhagic Escherichia coli.
June 1994, The Pediatric infectious disease journal,
Masaki Shimizu, and Mondo Kuroda, and Natsumi Inoue, and Michio Konishi, and Noboru Igarashi, and Hiromichi Taneichi, and Hirokazu Kanegane, and Mika Ito, and Shigeru Saito, and Akihiro Yachie
[Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome].
September 1997, Wiener klinische Wochenschrift,
Masaki Shimizu, and Mondo Kuroda, and Natsumi Inoue, and Michio Konishi, and Noboru Igarashi, and Hiromichi Taneichi, and Hirokazu Kanegane, and Mika Ito, and Shigeru Saito, and Akihiro Yachie
Treatment of enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome (eHUS).
June 2014, Seminars in thrombosis and hemostasis,
Masaki Shimizu, and Mondo Kuroda, and Natsumi Inoue, and Michio Konishi, and Noboru Igarashi, and Hiromichi Taneichi, and Hirokazu Kanegane, and Mika Ito, and Shigeru Saito, and Akihiro Yachie
Hemolytic Uremic Syndrome After an Escherichia coli O111 Outbreak.
October 2010, Archives of internal medicine,
Masaki Shimizu, and Mondo Kuroda, and Natsumi Inoue, and Michio Konishi, and Noboru Igarashi, and Hiromichi Taneichi, and Hirokazu Kanegane, and Mika Ito, and Shigeru Saito, and Akihiro Yachie
Role of complement in enterohemorrhagic Escherichia coli-Induced hemolytic uremic syndrome.
June 2014, Seminars in thrombosis and hemostasis,
Masaki Shimizu, and Mondo Kuroda, and Natsumi Inoue, and Michio Konishi, and Noboru Igarashi, and Hiromichi Taneichi, and Hirokazu Kanegane, and Mika Ito, and Shigeru Saito, and Akihiro Yachie
[Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome in Argentina].
January 2004, Medicina,
Masaki Shimizu, and Mondo Kuroda, and Natsumi Inoue, and Michio Konishi, and Noboru Igarashi, and Hiromichi Taneichi, and Hirokazu Kanegane, and Mika Ito, and Shigeru Saito, and Akihiro Yachie
Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli.
August 2008, Emerging infectious diseases,
Copied contents to your clipboard!